Design Therapeutics
(NASDAQ:DSGN)
$25.57
At close: Aug 15
$25.57
PreMarket: 4:02PM EDT
Day High/Low- - -
52 Week High/Low9.61 - 26.3
Open / Close- / -
Float / Outstanding- / 55.8M
Vol / Avg.- / 194.8K
Mkt Cap1.4B
P/E-
50d Avg. Price17.51
Div / Yield-
Payout Ratio-
EPS-0.27
Total Float28.9M

Design Therapeutics (NASDAQ:DSGN), Quotes and News Summary

Design Therapeutics (NASDAQ: DSGN)

Day High/Low- - -
52 Week High/Low9.61 - 26.3
Open / Close- / -
Float / Outstanding- / 55.8M
Vol / Avg.- / 194.8K
Mkt Cap1.4B
P/E-
50d Avg. Price17.51
Div / Yield-
Payout Ratio-
EPS-0.27
Total Float28.9M
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-08
REV
Q2 2022Est.ActualSurprise
EPS-0.270
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Design Therapeutics Questions & Answers

Q
How do I buy Design Therapeutics (DSGN) stock?
A

You can purchase shares of Design Therapeutics (NASDAQ: DSGN) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Design Therapeutics's (DSGN) competitors?
A

There are no as such competitors for Design Therapeutics.

Q
What is the target price for Design Therapeutics (DSGN) stock?
A

The latest price target for Design Therapeutics (NASDAQ: DSGN) was reported by Wedbush on Tuesday, August 9, 2022. The analyst firm set a price target for 26.00 expecting DSGN to rise to within 12 months (a possible 1.68% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Design Therapeutics (DSGN)?
A

The stock price for Design Therapeutics (NASDAQ: DSGN) is $25.57 last updated August 15, 2022, 8:00 PM UTC.

Q
Does Design Therapeutics (DSGN) pay a dividend?
A

There are no upcoming dividends for Design Therapeutics.

Q
When is Design Therapeutics (NASDAQ:DSGN) reporting earnings?
A

Design Therapeutics’s Q3 earnings are confirmed for Tuesday, November 8, 2022.

Q
Is Design Therapeutics (DSGN) going to split?
A

There is no upcoming split for Design Therapeutics.

Q
What sector and industry does Design Therapeutics (DSGN) operate in?
A

Design Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.